Summary Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in erythrocytes causes
acute haemolytic anaemia upon exposure to fava beans, drugs, or infection; and it …

Plasmodium vivax malaria continues to cause a significant burden of disease in the Asia-
Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8 …

Background To achieve malaria elimination, Brazil must implement Plasmodium vivax
radical cure. We aimed to investigate the operational feasibility of point-of-care, quantitative …

In remote communities, diagnosis of G6PD deficiency is challenging. We assessed the
impact of modified test procedures and delayed testing for the point-of-care diagnostic …

In their interesting and comprehensive paper in the February 2, 2023 issue of this journal,
Geck et al. 1 have illustrated several aspects of genetic variation at the X-linked G6PD locus …

Background The WHO recommends routine testing of G6PD activity to guide radical cure in
patients with Plasmodium vivax malaria. Females may have intermediate G6PD enzyme …

Objectives: Baise, a multiethnic inhabited area of southwestern China, is a historical malaria-
endemic area with a high prevalence of G6PD deficiency. However, few studies of G6PD …

Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the most
common enzymopathies in humans, present in approximately half a billion people …

Objectives: The prevalence of G6PD deficiency has not been reported in Yangjiang, a
western city in Guangdong province. This study aims to investigate the molecular …

Early malaria investigators were certainly correct in classifying the species falciparum and
the species vivax as belonging to the same genus, Plasmodium. Both are intraerythrocytic in …